Check back regularly for news and updates from SMFM.
Fetal growth restriction (FGR) is the final manifestation of a variety of maternal, fetal, and placental conditions. Fetal growth restriction occurs in up to 10% of pregnancies and is second to premature birth as a cause of infant morbidity and mortality. In addition to its significant perinatal... Continue Reading
The Society for Maternal-Fetal Medicine (SMFM) Fetal Anomalies Consult Series represents a collaborative effort to create an organ-based approach to the diagnosis, management, and treatment of fetal and placental anomalies. Each document in this series reviews a different fetal, placental, or... Continue Reading
The International Classification of Disease, 10th edition (ICD-10-CM), has a specific code category for umbilical cord complications (O69). However, the use of codes from this category is limited to the labor and delivery period. Using codes from this category during the antepartum period,... Continue Reading
Placenta accreta is defined as an abnormal invasion of all or part of the placenta into the myometrial wall of the uterus. Placenta accreta spectrum (PAS) is the more current terminology to refer to the range of abnormal placental invasion that includes placenta accreta, increta and percreta. ... Continue Reading
Placenta accreta spectrum, formerly known as morbidly adherent placenta, refers to the range of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of placenta accreta spectrum is that a... Continue Reading
Recently, our membership has had questions regarding the appropriate use and required components of CPT codes 76805, 76816 and 76815. This coding tip reviews the components of each imaging study, as well as provides some clinical scenarios of appropriate use: It is important to distinguish,... Continue Reading
Third-trimester bleeding is a common complication arising from a variety of etiologies, some of which may initially present in the late preterm period. Previous management recommendations have not been specific to this gestational age window, which carries a potentially lower threshold for... Continue Reading
Acetaminophen is the most widely used medicine during pregnancy. While the rate of use in pregnancy is difficult to determine because it is an over-the-counter medication, large surveys have reported that 40–65% of pregnant women use acetaminophen at some time during their pregnancy. The... Continue Reading
This document builds upon recommendations from peer organizations and outlines a process for identifying maternal cases that should be reviewed. Severe maternal morbidity is associated with a high rate of preventability, similar to that of maternal mortality. It also can be considered a near miss... Continue Reading
Vasa previa occurs when unprotected fetal blood vessels run through the amniotic membranes and traverse the cervix. Complications include fetal hemorrhage, exsanguination, or death. Diagnosis by ultrasound. Management: antenatal corticosteroids 28-32 weeks, considerations for preterm... Continue Reading
A recent question was asked on the correct way to report an Umbilical Cord Occlusion via the Radio Frequency Ablation approach”. Below you will find two examples of multi-fetal reductions, their approach and correct coding guidance for billing purposes. Types of Fetal Reductions and... Continue Reading
Chorionic Villus Sampling (CVS) is a prenatal test that detects chromosomal abnormalities such as Down syndrome, as well as a host of other genetic disorders.CVS is a diagnostic procedure which involves removing some chorionic villi cells from the placenta at the point where it attaches to the... Continue Reading
